Metraipolis › archive › dc_f7ee838cb582

CDKN2AIPNL: a potential pan-cancer biomarker — Europe PMC PMID:41640880

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41640880
DOI
10.3389/fgene.2025.1588292
License (as archived)
solo-consultazione
Archived
2026-11-06T15:40:48.927Z
SHA-256 of the archived text
3e55cb6cce8e1546b3c6c12112a43066f26eac939f167a3512a3db06388a7697
Stable URL of this page
https://metraipolis.com/documento/dc_f7ee838cb582

How to cite

CDKN2AIPNL: a potential pan-cancer biomarker — Europe PMC PMID:41640880 — Europe PMC (en), https://europepmc.org/article/MED/41640880 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f7ee838cb582 (Metraipolis archive dc_f7ee838cb582, sha256 3e55cb6cce8e1546b3c6c12112a43066f26eac939f167a3512a3db06388a7697)
BibTeX
@misc{dcf7ee838cb582,
  title = {CDKN2AIPNL: a potential pan-cancer biomarker — Europe PMC PMID:41640880},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41640880},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f7ee838cb582; sha256 3e55cb6cce8e1546b3c6c12112a43066f26eac939f167a3512a3db06388a7697},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41640880. Agents can read the archived copy with the MCP tool read_document.